Thailandepsins are new small molecule class I HDAC inhibitors with potent cytotoxic activity in ovarian cancer cells: a preclinical study of epigenetic ovarian cancer therapy
出版年份 2012 全文链接
标题
Thailandepsins are new small molecule class I HDAC inhibitors with potent cytotoxic activity in ovarian cancer cells: a preclinical study of epigenetic ovarian cancer therapy
作者
关键词
-
出版物
Journal of Ovarian Research
Volume 5, Issue 1, Pages 12
出版商
Springer Nature
发表日期
2012-04-25
DOI
10.1186/1757-2215-5-12
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
- (2011) R. L. Piekarz et al. BLOOD
- The DNA damage mark pH2AX differentiates the cytotoxic effects of small molecule HDAC inhibitors in ovarian cancer cells
- (2011) Andrew J. Wilson et al. CANCER BIOLOGY & THERAPY
- Schedule-dependent synergy of histone deacetylase inhibitors with DNA damaging agents in small cell lung cancer
- (2011) Victoria L. Luchenko et al. CELL CYCLE
- Thailandepsins: Bacterial Products with Potent Histone Deacetylase Inhibitory Activities and Broad-Spectrum Antiproliferative Activities
- (2011) Cheng Wang et al. JOURNAL OF NATURAL PRODUCTS
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Total Synthesis and Stereochemical Assignment of Burkholdac B, a Depsipeptide HDAC Inhibitor
- (2011) Hanae Benelkebir et al. ORGANIC LETTERS
- Residual γH2AX foci as an indication of lethal DNA lesions
- (2010) Judit P Banáth et al. BMC CANCER
- Hdac3 Is Essential for the Maintenance of Chromatin Structure and Genome Stability
- (2010) Srividya Bhaskara et al. CANCER CELL
- Inhibition of Histone Deacetylase in Cancer Cells Slows Down Replication Forks, Activates Dormant Origins, and Induces DNA Damage
- (2010) Chiara Conti et al. CANCER RESEARCH
- In vitro and in vivo histone deacetylase inhibitor therapy with vorinostat and paclitaxel in ovarian cancer models: Does timing matter?
- (2010) Susan C. Modesitt et al. GYNECOLOGIC ONCOLOGY
- Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair
- (2010) J.- H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enhancing the apoptotic and therapeutic effects of HDAC inhibitors
- (2009) Ailsa J. Frew et al. CANCER LETTERS
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
- (2009) Richard L. Piekarz et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA fingerprinting of the NCI-60 cell line panel
- (2009) P. L. Lorenzi et al. MOLECULAR CANCER THERAPEUTICS
- HDAC4 Promotes Growth of Colon Cancer Cells via Repression of p21
- (2008) Andrew J. Wilson et al. MOLECULAR BIOLOGY OF THE CELL
- Deletion of Histone Deacetylase 3 Reveals Critical Roles in S Phase Progression and DNA Damage Control
- (2008) Srividya Bhaskara et al. MOLECULAR CELL
- The many roles of histone deacetylases in development and physiology: implications for disease and therapy
- (2008) Michael Haberland et al. NATURE REVIEWS GENETICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now